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The ~F-~u-bi~~~ng center of the E. EC& ribosome has been localized by ~rnu~~el~c~on microcopy &er 
cross-M&g of the specific EF-Tu-70 S ribasomaf corn@ with dimethyfsuberimidate. EF-Tu has been 
found to be in contact with the 50 S subunit in the region of the LJ/L12 stak and with the 30 S subunit 
in the upper part of its body on the side opposite the top of the ledge (the platform). The EF-Tu position 
on a model of the 70 S ribosome is presented. 
1. INTRODUCTION 
EIungatio~ factor Tu (E~~T#~ pIays a funda- 
mentaf role in protein biosynthesis, promoting the 
codon-dependent binding of aminoacyl-tRNA to 
the ribosome. The importance of determining the 
ribosomal region interacting with EF-Tu is evi- 
dent. Numerous in~~s~gations u ing crow-~i~kiug 
ff,2], singtet energy transfer technique Pfi inhibi- 
tion by ribasomal protein-specific antibodies f4], 
ribosomal protein omission tests [5-71, etc, have 
left this question still open, 
This paper describes experiments on a direct 
caption of EF-Tu on the ribosome by immuno- 
electron microscopy. 
2. MATERIALS AND METHODS 
Tight 70 S ribosome couples were prepared from 
JZ_ coil MRE 600 as described in f8]_ Samples of 
e~~trophoret~caI~y homogeneous EF-Tu - GDP 
and EF-Ts were kindly provided by Dr 0, Stengrc- 
vies (Institute of Applied Biochemistry, Qlaine, 
USSR). tRNAphe was from Boehringer Mannheim 
(1.5 nmol Pfre/A&. 3H labeling of EF-Tu - GDP 
was carried out by reductive methy~ation 191 with 
I mM formaldehyde in the presence of NaB3H.+ 
(Amersham, 8 Ci/mmoI) in Q* f M borate (pH 9.0), 
5 mM MgC12, 100 mM KC& 2 mM &mercapto- 
ethanol and 20 yM GDP; the specific activity of 
the preparation was I-2.5X IO’ cpm per pmof. 
Specific rabbit antisera against EF-Tu . GDP were 
prepared by a standard technique. The IgG frac- 
tion was purified by (NH&SO4 fractionation, 
chromatography on DE 52 and gel filtration on 
Sephadex G-200 and stored at -WC in 50 m&I 
Tris-HCt (pH 7.51, 150 mM NH&Z, 8 mM MgC4, 
f 0 mM ~-mercapto~t~anol(30 mg protein/ml). An 
Ouchterlony test showed that IgC did not react 
with ribosomes and isolated protein L12. 
The ternary complex 13H]EF-Tu + GMPPCP . 
~~z~]Phe-tRNAp~e (complex I) was prepared via 
two steps: (if an eq~imo~ar mixture of f3H]EF- 
Tu + QDP and EF-T’s (IS nmoI/mt each) was in- 
cubated for IO min at 30°C in the presence of 20 
mM EDTA, 20 mM Bicine (pH 8.2) and the [3H]- 
EF-Tu - Ts complex was isolated on Sephadex G-50 
in 20 mM Bicine (PM 8.2& 2 mM EDTA and 2 mM 
~-m~rcaptoetb~oI 1121; (ii) then an eqnimofar 
amount of [‘2C]Phe-tRNAPhC was added and also 
GMPPCP, MgClz and KC1 to 1, 10 and 100 mM, 
respectively, and the mixture was incubated for 5 
min at 30°C. The complex ribosome . poiy(U) - 
tRNAPhe (complex XI) was prepared separately: an 
equimofar mixture of the ribosomes anct deacyIated 
tRNAPhe (250 pmoX each) and I.8 .&do of poIy(U) 
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(Mr about 2x 104) in 20 mM Bicine (pH 8.2), 10 
mM MgC12, 100 mM KC1 (final volume 120 al) 
were incubated for 5 min at 30°C. Complexes I 
and II were mixed in a ratio of 1.2 : 1 (final volume 
200~1) and, after 10 min incubation at 30°C cool- 
ed in ice. l/16 vol. of a fresh 80 mM solution of 
dimethylsuberimidate (Pierce) in 0.5 M Bicine (pH 
8.2) was added and the mixture was incubated for 
10 h in ice. The excess of the reagent was inac- 
tivated with NH&Z1 (0.1 M). 
According to centrifugation in a 5-20070 sucrose 
gradient the product of cross-linking contained 
about 8-10 mol [3H]EF-Tu per 100 mol ribosomes. 
The cross-linked 70 S ribosomes or their subunits 
were purified by repeated centrifugation in the 
sucrose gradient and concentrated by PEG 6000 
precipitation. 
The pellets were dissolved in 10 mM Tris-HCl 
(pH 7.5), 100 mM NH&l, 10 or 2 mM MgC12 and 
incubated with antibody against EF-Tu for 30 min 
in ice. The amount of antibody for optimal forma- 
tion of the 50 S and 30 S dimers was 30 and 4Opg 
per pmol cross-linked EF-Tu, respectively. 
Analysis of the product was carried out by 5-200;/0 
sucrose gradient centrifugation in the above buf- 
fers. After sucrose removal by dialysis, the dimer 
fractions were negatively stained with uranyl 
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Fig.1. Specificity of [3H]EF-Tu cross-linking with the 
ribosome by dimethylsuberimidate. ( o---o) Whole 
mixture, (x-x) same but without the reagent, (c--o) 
same but without poly(U), (A-4) the mixture contain- 
ing only [3H]EF-Tu. Ts, ribosome and reagent, (---) 
Fig.2. Accessibility to antibody action at 10 or 2 mM 
MgClz of [3H]EF-Tu specifically cross-linked with the 
ribosome. Mixtures: 130 pmol ribosomes (10.6 pmol 
cross-linked factor) f 0.33-1.0 mg antibody at 10 mM 
MgClz or f 0.33 mg antibody at 2 mM MgC12. (o--o) 
Without antibody, (M) in the presence of antibody, 
A260. (---) A260. 
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acetate using the single-layer carbon technique [lo] 
and examined in a JEM-1OOC microscope. 
3. RESULTS 
As in the case of EF-G [l I], the localization of 
EF-Tu on the ribosome by immunoelectron micros- 
copy requires prior fixation of the readily 
dissociating complex of the factor with the 
ribosome. To this end we used cross-linking of the 
complex with dimethylsuberimidate. The results 
are shown in fig.1. As seen, in the whole system 
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Fig.3. Interaction of the antibody with [3H]EF-Tu cross- 
linked in the ribosome with the 50 S subunit. (+---e) 
Without antibody (120 pmol 50 S, 5 pmol cross-linked 
factor), (M) plus 0.15 mg antibody, (s) same 
as preceding data, but in the presence of native EF-Tu 
(60 pmol), (A--A) same as (O---o) but in the presence 
of purified protein L12 (2.6 nmol). 
13H]EF-Tu cross-links with both the ribosomal 
subunits. In the absence of poly(U) cross-linking 
sharply decreases. Treatment of only the mixture 
of [3H]EF-Tus Ts and ribosomes with the reagent 
in the absence of the other components does not 
lead to efficient cross-linking. In other words, the 
appearance of the radioactive label, i.e. 13H]EF- 
Tu, in fractions of the ribosomal subunits is due to 
the formation of the specific complex between the 
factor and the ribosome. 
Fig.2 shows the accessibility of cross-linked EF- 
Tu to antibodies at 10 and 2 mM MgC12, i.e. under 
conditions of association and dissociation of the 
ribosome, respectively. The result is that the in- 
teraction of the antibody with the cross-linked fac- 
tor requires the previous dissociation of the 70 S 
ribosome. Therefore, electron microscopy was per- 
formed after treatment of the isolated ribosomal 
subunits with the antibody. 
Fig.3 shows the specificity of the antibody in- 
teraction with [3H]EF-Tu cross-linked in the 70 S 
ribosomal complex to the 50 S subunits. On in- 
cubation with an optimal amount of antibody, 
about 50% of the radioactive label shifts to the 
region of the 50 S dimers. Treatment of the mix- 
ture containing an excess of added native EF-Tu 
with the antibody does not lead to dimer forma- 
tion. At the same time the presence of an excess of 
protein L12 (or 50 S subunits, not shown) does not 
affect the yield of dimers. This means that dimer 
formation reflects the specific interaction of the 
antibody with the cross-linked [3H]EF-Tu. 
Electron micrographs of the preparation from 
the 50 S dimer fraction are presented in fig.4. We 
have analyzed a total of 150 and 40 images of the 
dimers and monomers, respectively, as shown in 
fig.4b-d. The predominant view of the 50 S sub- 
units is a crown-like one. In this view, antibody 
molecules attach to the stalk of protein L7/L12 or 
its base. In the infrequently observed kidney view, 
the antibodies attach to the base of the stalk always 
from the interface side of the 50 S subunit. Other 
antibody-binding sites occur very rarely (~5% of 
the total). 
For the 30 S subunits (fig.5) we have examined 
160 dimers and 30 monomers. In the intermediate 
views (fig.Sb), the antibodies attach to the upper 
frontal part of the 30 S body and in the frontal 
view (fig.5c) to the left (non-interface) side of the 
subunit. Hence, the antibody-binding site is located 
Fig.4. Electron micrographs of the 50 S subunits with cross-linked EF-Tu after reaction with the antibodies. (a) Field 
of large subunits. Arrows indicate antibodies in the 50 S. IgG .50 S complexes. (b) Gallery of the 50 S subunits linked 
with antibody in a characteristic rown-like view [12], as shown schematically to the right. The antibodies attach to the 
different parts of the L7/L12 stalk. (c) Antibodies attach to the upper subunit of each pair in the region of the base 
of the stalk. The two first frames represent ‘crown-crown’ types of images as shown schematically to the right. In the 
kidney view, antibodies attach to the concave (interface) side of the subunit (lower subunit in the third frame). This 
was observed in all 17 images of the subunit in the kidney view, which were found and examined. The fourth frame 
shows the 50 S s IgG .30 S complex with typical antibody-binding sites on both large and small ribosomal subunits. (d) 
Single subunits with antibodies attached. 
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Fig.6. Localization of EF-Tu on the ribosome. The position of the EF-Tu is denoted by hatching on: (a) the exterior 
and frontal sides of the 30 S subunit model 113,151, (b) the interface and lateral sides of the 50 S subunit model 1121, 
and (c) the 70 S ribosome model [14,15] approximately in overlap and non-overlap views. The position of EF-G [l I] 
is shown also for comparison. 
on the upper part of the 30 S body approximately 
apposite the top of its ledge. This site is observed 
in more than 90% of the images analyzed. In rare 
cases (< 10%) the antibody appears to be con- 
netted to the ledge (Wo), head (3Oro) or other 
regions (1070). It is likely that these minor sites are 
unspecific and have no relation to the real location 
of EF-Tu. 
4, ~rscusSr~~ 
The results of immunoelectron microscopic ana- 
lysis of the ribosomal subunits containing cross- 
linked EF-Tu can be formulated as follows (fig.6): 
(i) The zone of interactions of EF-Tu with the 
50 S subunit covers the L7/L12 stalk and its base; 
(ii) EF-Tu contacts with the 30 S subunit in the 
upper part of its body on the side opposite the top 
of the ledge. 
From a comparison of these data with a made1 
of the 70 S ribosome [14,15], it follows that both 
the zones described above are found in the same 
region of the 70 S ribosome. This permits us to 
outline correctly the region of the likely contacts of 
the EF-Tu molecule with the ribosomal surface 
(fig.6c). For comparison, the position of the EF-G- 
binding site localized by us eartier [I 1] is also 
shown. Both sites seem to be close to each other or 
perhaps even overlap, but do not coincide. EF-G is 
located deeper in the ribosomal interface, contact- 
ing with the 30 S subunit in the groove between its 
head and body and with the 50 S subunit at the 
base of the L7/L12 stalk but without visible con- 
tact with the stalk itself. EF-Tu is located nearer to 
Fig.% Electron micrographs of the 30 S subunits with cross-finked EF-Tu after reaction with the antibodies. (af Field 
of the preparation. Arrows indicate antibodies in the 30 S = I&i. 30 S complexes. fbj GaiIery of pairs of small subunits 
linked by antibody. The subunits in pairs are in characteristic intermediate (45 and 225”) views [13]* as shown 
s~he~ati~~~y in the first frame. The antibodies attach to the upper frontai part of the subunit body. (c) Vertically 
oriented subunits in the pair and in the monomeric complexes are in a frontal view. The antibodies attach to the left 
side of the subunit which is its int.erface side [14,15]. An interpretative drawing is shown in the first frame. 
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the ribosom~ periphery, contacting with the 30 S 
subunit distinctly below EF-G and interacting by a 
substantial area of its surface with the L7/L12 
stalk. 
Numerous investigations of the interaction of 
EF-Tu with ~inoacyl-tRNA show that these mole- 
cules have a fairly large contact surface (16-191 
(the consequence of such a large contact surface 
can be significant protection of the factor antigenic 
determinants against the antibody action in the 
functional EF-Tu + 70 S ribosomal complex; see fig. 
2A). In the proposed model of the EF-Tu - tRNA 
complex, the tRNA lies parallel to the factor mole- 
cule with the acceptor end located on domain 1 of 
the factor [20] and with the anticodon end pro- 
truding from its domain 3 [19]. As the anticodon 
and acceptor ends of the tRNA are located on the 
30 S and 50 S subunits, respectively, then, in ac- 
cordance with this model, the EF-Tu molecule 
must be placed in such a way that its domains 1 
and 2 form contacts mainly with the L7/L12 stalk 
and/or its base on the 50 S subunit while domain 
3 contacts with the upper part of the 30 S subunit 
body. 
In conclusion, the location of EF-Tu on the 
ribosome shown above is the most direct experi- 
mental evidence in favour of a model of the amino- 
acyl-tRNA binding site being near the base of the 
L7/L12 stalk [21]. In fig& the aminoacyl-tRNA 
will lie above the EF-Tu molecule (perhaps adjoin- 
ing the EF-G-binding site) so that its anticodon is 
in the groove between the head and the body of the 
30 S subunit and the acceptor end is directed 
towards the base of the 50 S central protuberance. 
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